Literature DB >> 9783985

Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma.

A Kugler1, B Hemmerlein, P Thelen, M Kallerhoff, H J Radzun, R H Ringert.   

Abstract

Degradation of the extracellular matrix is necessary for invasion and metastasis by cancer cells. Two gelatinolytic matrix metalloproteinase enzymes, MMP-2 and MMP-9, are supposed to be key enzymes in this process. The purpose of this study was to correlate the presence of MMP-2, MMP-9 and their inhibitors with the tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2 RNA using reverse transcriptase PCR technique with tumor stage in 17 samples of renal cell carcinoma. The ratio of tissues expressing MMP-2 and MMP-9 to those expressing TIMP-1 and TIMP-2 was defined to be 1 in normal kidney tissue. This MMP:TIMP ratio was significantly increased to 2.43 (standard deviation, SD = 0.8) in locally confined renal cell carcinoma and to 4.86 (SD = 1.1) in advanced carcinoma (p <0.01). In primary tumor cell lines the ratio of MMP:TIMP expression was 3.44 (SD = 0.6). These data suggest that the balance of MMP-2 and MMP-9 to TIMP-1 and TIMP-2 expression is an essential factor in the aggressiveness of renal cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9783985

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  18 in total

1.  Differential modulatory effects of clarithromycin on the production of cytokines by a tumor.

Authors:  K Sassa; Y Mizushima; M Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

2.  Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma.

Authors:  J W Slaton; K Inoue; P Perrotte; A K El-Naggar; D A Swanson; I J Fidler; C P Dinney
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 3.  Prognostic factors in renal cell carcinoma.

Authors:  Alessandro Volpe; Jean Jacques Patard
Journal:  World J Urol       Date:  2010-04-03       Impact factor: 4.226

4.  Insulin-like growth factor binding protein 7 and tissue inhibitor of metalloproteinases-2: differential expression and secretion in human kidney tubule cells.

Authors:  David R Emlet; Nuria Pastor-Soler; Allison Marciszyn; Xiaoyan Wen; Hernando Gomez; William H Humphries; Seth Morrisroe; Jacob K Volpe; John A Kellum
Journal:  Am J Physiol Renal Physiol       Date:  2016-12-21

5.  May High MMP-2 and TIMP-2 Expressions Increase or Decrease the Aggressivity of Oral Cancer?

Authors:  Bijayatha Shrestha; Dipshikha Bajracharya; Aditi Amit Byatnal; Asha Kamath; Raghu Radhakrishnan
Journal:  Pathol Oncol Res       Date:  2016-11-16       Impact factor: 3.201

Review 6.  Proteolytic-antiproteolytic balance and its regulation in carcinogenesis.

Authors:  Elzbieta Skrzydlewska; Mariola Sulkowska; Mariusz Koda; Stanislaw Sulkowski
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

7.  Suppression of matrix metalloproteinase activity by SI-27: detection by a new activity assay with S-2444, a specific chromogenic peptide.

Authors:  Daizo Yoshida; Kunihiro Watanabe; Masahiro Noha; Hiroshi Takahashi; Akira Teramoto
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

Review 8.  Invasion and metastasis of renal cell carcinoma.

Authors:  Shuji Mikami; Mototsugu Oya; Ryuichi Mizuno; Takeo Kosaka; Ken-ichi Katsube; Yasunori Okada
Journal:  Med Mol Morphol       Date:  2013-11-09       Impact factor: 2.309

9.  Underactivation of the adiponectin-adiponectin receptor 1 axis in clear cell renal cell carcinoma: implications for progression.

Authors:  Nir Kleinmann; Wilhelmina C M Duivenvoorden; Sarah N Hopmans; Laura K Beatty; Shengjun Qiao; Daniel Gallino; Sarka Lhotak; Dean Daya; Athanasios Paschos; Richard C Austin; Jehonathan H Pinthus
Journal:  Clin Exp Metastasis       Date:  2013-10-05       Impact factor: 5.150

10.  Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survival.

Authors:  Ferhat Ozden; Caner Saygin; Didem Uzunaslan; Bulent Onal; Haydar Durak; Hilal Aki
Journal:  J Cancer Res Clin Oncol       Date:  2013-05-25       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.